VOGLIGOLD M 0.3

VOGLIGOLD M 0.3 is a fixed-dose combination medicine for Type 2 Diabetes Mellitus, containing voglibose (an alpha-glucosidase inhibitor) and metformin hydrochloride (a biguanide anti-diabetic drug).

• Voglibose 0.3 mg works by delaying carbohydrate breakdown in the intestines, reducing postprandial blood sugar spikes.

• Metformin Hydrochloride 500 mg reduces glucose production in the liver and improves insulin sensitivity, helping to control fasting blood sugar levels.

Together, they provide comprehensive blood sugar management when combined with diet and exercise.

Uses of Voglibose and Metformin Hydrochloride Tablets

The main voglibose and metformin hydrochloride tablets uses include:

• Management of Type 2 Diabetes Mellitus.

• Reduction of both fasting and post-meal blood sugar levels.

• Prevention of long-term complications of diabetes such as nerve damage, kidney problems, heart issues, and eye disorders.

• Often prescribed when single-drug therapy is insufficient.

Side Effects of VOGLIGOLD M 0.3

Some patients may experience side effects while taking voglibose 0.3 metformin 500, including:

Common Side Effects:

• Flatulence (gas)

• Abdominal discomfort or bloating

• Diarrhea

• Nausea or vomiting

• Loss of appetite

• Metallic taste in mouth

• Headache

• Mild skin rash or itching

Less Common Side Effects:

• Constipation

• Fatigue or weakness

• Indigestion

• Increased bowel sounds (borborygmi)

• Dizziness

Rare but Serious Side Effects:

• Lactic acidosis (a rare but potentially serious effect of metformin – symptoms include muscle pain, severe tiredness, breathing difficulty)

• Hypoglycemia (low blood sugar), especially if taken with other anti-diabetic drugs like insulin or sulfonylureas

Precautions Before Using VOGLIGOLD M 0.3

Before taking voglibose and metformin hydrochloride tablets, inform your doctor if you:

• Have kidney or liver disease.

• Suffer from heart failure or breathing problems.

• Have a history of intestinal obstruction or chronic digestive issues.

• Consume alcohol frequently (increases risk of lactic acidosis).

• Are pregnant, breastfeeding, or planning pregnancy.

• Are allergic to voglibose, metformin, or similar drugs.

Drug Interactions – What Drugs Interact with VOGLIGOLD M 0.3?

Certain medicines can interact with voglibose 0.3 metformin 500:

• Sulfonylureas (e.g., glimepiride, glibenclamide) – may cause hypoglycemia.

• Insulin – increases the risk of low blood sugar.

• Diuretics – may increase lactic acidosis risk with metformin.

• Corticosteroids – may raise blood sugar levels.

• Beta-blockers – may mask signs of hypoglycemia.

• Iodinated contrast agents – may harm kidney function and increase lactic acidosis risk.

• Digestive enzymes (e.g., amylase, pancreatin) – may reduce voglibose’s effect.